In a report released today, Josh Jennings from TD Cowen maintained a Hold rating on Zimmer Biomet Holdings (ZBH – Research Report), with a price target of $119.00. Josh Jennings has given his ...

Zimmer Biomet Holdings Inc是一家肌肉骨骼保健公司。该公司从事骨科重建产品的设计、制造和营销；运动医学、生物制品、四肢和创伤产品；脊柱、颅颌面和胸部（CMFT）产品；牙科植入物和相关的外科产品。该公司的产品和解决方案帮助治疗患有骨骼、关节或支撑软 ...

Zimmer Biomet Holdings, Inc. (NYSE:ZBH), a leading medical device company specializing in musculoskeletal healthcare, finds itself at a critical juncture as it navigates through enterprise ...

NEW YORK - Zimmer Biomet Holdings, Inc. (NYSE:ZBH) reported third-quarter results that met analyst expectations, while narrowing its full-year guidance range. The medical device maker's shares ...

Good morning, ladies and gentlemen, and welcome to the Zimmer Biomet Third Quarter 2024 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded today ...

(RTTNews) - Medical technology company Zimmer Biomet Holdings, Inc. (ZBH) announced Monday plans for the broad commercial launch of the Z1 Femoral Hip System (Z1 System) for total hip arthroplasty ...

President and Chief Executive Officer of Zimmer Biomet. "Through a series of strategic acquisitions and in-house innovations, we've curated a diversified portfolio of hip implant solutions and ...

(RTTNews) - Zimmer Biomet Holdings Inc. (ZBH) revealed earnings for its third quarter that increased from last year and beat the Street estimates. The company's earnings came in at $249.1 million ...

WARSAW, Ind., Oct. 28, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced plans for the broad commercial launch of the Z1™ ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...